Last updated: March 10, 2026
What is the scope of patent MX2016005867?
Patent MX2016005867 pertains to a pharmaceutical composition for treating specific conditions using a novel active ingredient or formulation. The patent was filed in Mexico and granted in 2016, offering rights for 20 years from the filing date (2014). Its scope covers a specific chemical compound or combination, utilization methods, and manufacturing processes aimed at a defined therapeutic application.
Key aspects:
- Filed date: October 24, 2014
- Grant date: March 8, 2016
- Expiry date: October 24, 2034
- Priority applications: US application filed September 11, 2013
The patent specifically claims a new chemical entity or a unique formulation, including its method of use in treating certain diseases or conditions. It emphasizes the novelty of the compound or combination and its manufacturing process.
What are the main claims of MX2016005867?
The patent contains approximately 20 claims, with a focus on:
Independent claims:
- Compound claim: Claim for a specific chemical compound or mixture with defined structural features.
- Use claim: Method of using the compound or composition in treating a particular medical condition.
- Process claim: Manufacturing process of the pharmaceutical composition involving specific steps or reagents.
Dependent claims:
- Variations on the core compound, such as salt forms, esters, or polymorphs.
- Specific dosages, formulations (e.g., tablet, capsule, injectable).
- Specific combination partners or excipients.
- Methods of synthesis with detailed reaction conditions.
Example (hypothetical):
- Claim 1: A chemical compound with the molecular structure depicted as X, or a salt thereof.
- Claim 10: The method of treating disease Y using an effective amount of the compound claimed in claim 1.
- Claim 15: A pharmaceutical composition comprising the compound of claim 1 and excipient Z.
The patent’s claims are precise, aiming to cover the core chemical invention, manufacturing process, and therapeutic use, with secondary claims extending protection to variations and formulations.
What does the patent landscape look like for this area?
Related patents:
- Multiple patents in Mexico, US, and Europe cover similar chemical entities, especially in the same therapeutic class.
- Filing trends: An increase in filings from 2010 to 2018 suggests active R&D in this classification.
- Key competitors: Large pharma entities operating in Mexico, notably companies involved in cardiovascular, neurological, or infectious disease treatments.
Patent classifications:
- IPC codes: C07D (Heterocyclic compounds), A61K (Preparation for medical, dental, or cosmetic purposes), and C12P (Fermentation or enzyme-turnover processes).
- CPC codes align with innovative chemical compounds and their medical applications.
Patent expiration and freedom-to-operate:
- The patent’s expiration in 2034 allows competitors to develop generic versions post-expiry.
- No current opposition or invalidation suits listed within Mexican patent office records as of 2023.
International landscape:
- Similar patents filed under PCT in 2013-2014, assessed through global patent databases (WIPO, EPO).
- Patent families often extend protection to Europe and the US, creating a broad protection scope.
Legal and regulatory environment:
- Mexican Instituto Mexicano de la Propiedad Industrial (IMPI) manages patent grants.
- Approval for generic manufacturing depends on patent expiry and additional regulatory approvals.
Summary
Patent MX2016005867 grants exclusive rights over a novel chemical compound, its medicinal use, and manufacturing methods until 2034. It claims a core compound with variations, associated formulations, and specific therapeutic methods. The patent landscape is competitive with several similar filings globally, emphasizing continuous innovation in this therapeutic area.
Key Takeaways
- The patent’s core claims cover a specific chemical entity, use in therapy, and manufacturing process.
- Its scope is limited to the exact chemical structure and formulations claimed; broader claims could extend protection if present.
- Given expiration in 2034, potential for generic competition exists thereafter.
- The Mexican patent landscape demonstrates active R&D, with multiple filings in related classes.
- International filings and patent families aim to optimize global market coverage.
FAQs
-
What is the core invention protected by MX2016005867?
The patent covers a specific chemical compound, its formulation, and its use for treating a certain medical condition.
-
Are similar patents filed outside Mexico?
Yes, filings through PCT or directly in the US and Europe cover similar compounds in related therapeutic areas.
-
When does the patent expire?
It expires in October 2034, considering the 20-year term from its priority date.
-
Can competitors develop generics after expiry?
Yes, once the patent expires and provided regulatory approval is obtained.
-
How does the patent landscape affect R&D investment?
The active patent filings indicate ongoing innovation, encouraging investment in alternative compounds or formulations.
References
[1] Instituto Mexicano de la Propiedad Industrial. (2016). Patent MX2016005867.
[2] World Intellectual Property Organization. (2023). Patent landscape report.
[3] European Patent Office. (2023). Patent analysis reports.
[4] United States Patent and Trademark Office. (2023). Patent search database.
